BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 15147144)

  • 1. Intravenous immunoglobulin (IVIG): modes of action in the clinical management of recurrent pregnancy loss (RPL) and selected autoimmune disorders.
    Omwandho CO; Gruessner SE; Roberts TK; Tinneberg HR
    Clin Chem Lab Med; 2004 Apr; 42(4):359-70. PubMed ID: 15147144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of intravenous immunoglobulin in recurrent pregnancy loss associated with combined alloimmune and autoimmune abnormalities.
    Kiprov DD; Nachtigall RD; Weaver RC; Jacobson A; Main EK; Garovoy MR
    Am J Reprod Immunol; 1996 Oct; 36(4):228-34. PubMed ID: 8911631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of immunologic recurrent pregnancy loss.
    Stern JJ; Coulam CB
    Curr Opin Obstet Gynecol; 1993 Apr; 5(2):252-9. PubMed ID: 8490097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alloimmune and autoimmune background in recurrent pregnancy loss - successful immunotherapy by intravenous immunoglobulin.
    Kotlan B; Padanyi A; Batorfi J; Fulop V; Szigetvari I; Rajczy K; Penzes M; Gyodi E; Reti M; Petranyi G
    Am J Reprod Immunol; 2006 May; 55(5):331-40. PubMed ID: 16635207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent pregnancy losses and the role of immunotherapy.
    Omwandho CA; Tinneberg HR; Tumbo-Oeri AG; Roberts TK; Falconer J
    Arch Gynecol Obstet; 2000 Jul; 264(1):3-12. PubMed ID: 10985611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alloimmune causes of recurrent pregnancy loss.
    Porter TF; Scott JR
    Semin Reprod Med; 2000; 18(4):393-400. PubMed ID: 11355798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous Immunoglobulin G Improves Pregnancy Outcome in Women with Recurrent Pregnancy Losses with Cellular Immune Abnormalities.
    Lee SK; Kim JY; Han AR; Hur SE; Kim CJ; Kim TH; Cho BR; Han JW; Han SG; Na BJ; Kwak-Kim J
    Am J Reprod Immunol; 2016 Jan; 75(1):59-68. PubMed ID: 26510488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intravenous immunoglobulin (IVIG) as treatment for recurrent pregnancy loss (RPL)].
    Sapir T; Carp H; Shoenfeld Y
    Harefuah; 2005 Jun; 144(6):415-20, 454, 453. PubMed ID: 15999561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulin for recurrent unexplained pregnancy loss: a case report.
    Barnsfather K; Pietrantoni M
    J Reprod Med; 2007 Aug; 52(8):737-40. PubMed ID: 17879838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obstetric uses of intravenous immunoglobulin: successes, failures, and promises.
    Branch DW; Porter TF; Paidas MJ; Belfort MA; Gonik B
    J Allergy Clin Immunol; 2001 Oct; 108(4 Suppl):S133-8. PubMed ID: 11586281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does immunotherapy for treatment of reproductive failure enhance live births?
    Coulam CB; Acacio B
    Am J Reprod Immunol; 2012 Apr; 67(4):296-304. PubMed ID: 22340745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy with intravenous immunoglobulin for prevention of recurrent pregnancy loss: European experience.
    Mueller-Eckhardt G
    Am J Reprod Immunol; 1994 Dec; 32(4):281-5. PubMed ID: 7718094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss.
    Sapir T; Blank M; Shoenfeld Y
    Ann N Y Acad Sci; 2005 Jun; 1051():743-78. PubMed ID: 16127014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy with intravenous immunoglobulin for treatment of recurrent pregnancy loss: American experience.
    Coulam CB
    Am J Reprod Immunol; 1994 Dec; 32(4):286-9. PubMed ID: 7718095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking antibodies in blood from patients with recurrent spontaneous abortion in relation to pregnancy outcome and intravenous immunoglobulin treatment.
    Jablonowska B; Palfi M; Ernerudh J; Kjellberg S; Selbing A
    Am J Reprod Immunol; 2001 Apr; 45(4):226-31. PubMed ID: 11327549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological problems in the recurrent abortion syndrome.
    Perino A; Barba G; Cimino C; Costa P; Pignatone C; Scaglione G; Zangara C; Cittadini E; Marcenò R; Indovina A
    Acta Eur Fertil; 1989; 20(4):199-202. PubMed ID: 2519571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adoptive-transfer effects of intravenous immunoglobulin in autoimmunity.
    Lazarus AH
    J Clin Immunol; 2010 May; 30 Suppl 1():S20-3. PubMed ID: 20401687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulin for treatment of recurrent pregnancy loss.
    Coulam CB; Krysa L; Stern JJ; Bustillo M
    Am J Reprod Immunol; 1995 Dec; 34(6):333-7. PubMed ID: 8607936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal thrombocytopenia as side effect of immunotherapy for recurrent spontaneous abortion.
    Deligiannidis A; Parapanissiou E; Mavroudi A; Papastavrou T
    Am J Reprod Immunol; 2007 Mar; 57(3):167-8. PubMed ID: 17295894
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravenous immunoglobulin use in patients with unexplained recurrent pregnancy loss.
    Banjar S; Kadour E; Khoudja R; Ton-Leclerc S; Beauchamp C; Beltempo M; Dahan MH; Gold P; Jacques Kadoch I; Jamal W; Laskin C; Mahutte N; Reinblatt SL; Sylvestre C; Buckett W; Genest G
    Am J Reprod Immunol; 2023 Aug; 90(2):e13737. PubMed ID: 37491929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.